THE ACCURACY OF RETROPERITONEAL ULTRASONOGRAPHY IN HODGKIN'S DISEASE AND NON-HODGKIN'S LYMPHOMA.BRASCHO DJ; DURANT JR; GREEN LE et al.1977; RADIOLOGY; U.S.A.; DA. 1977; VOL. 125; NO 2; PP. 485-487; BIBL. 6 REF.Article

EVALUATION OF A COOPERATIVE GROUP HUMAN MYELOMA PROTOCOL USING THE MOPC 104E MYELOMA MODEL = EVALUATION DU PROTOCOLE POUR LE MYELOME HUMAIN DU GROUPE DE COLLABORATION A L'AIDE DU MODELE DU MYELOME MOPC 104EHIRAMOTO R; VITHAL GHANTA; DURANT JR et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 5; PP. 1309-1313; BIBL. 14REF.Article

MUCOSAL EOSINOPHILIC GASTROENTERITIS WITH SYSTEMIC INVOLVEMENT.ROBERT F; OMURA E; DURANT JR et al.1977; AMER. J. MED.; U.S.A.; DA. 1977; VOL. 62; NO 1; PP. 139-143; BIBL. 21 REF.Article

A MULTI-INSTITUTIONAL PHASE III STUDY OF NABILONE VS. PLACEBO IN CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING = ESSAI COOPERATIF PHASE III COMPARANT NABILONE ET PLACEBO DANS LES VOMISSEMENTS AU COURS DE LA CHIMIOTHERAPIEJONES SE; DURANT JR; GRECO FA et al.1982; CANCER TREATMENT REVIEWS; ISSN 0305-7372; GBR; DA. 1982-12; VOL. 9; SUPPL.; PP. 45-48; ABS. ENG; BIBL. 3 REF.; GRAPHArticle

PROVOKED PRIAPISM IN SICKLE CELL ANEMIACONRAD ME; PERRINE GM; BARTON JC et al.1980; AM. J. HEMATOL.; ISSN 0361-8609; USA; DA. 1980; VOL. 9; NO 1; PP. 121-122; BIBL. 4 REF.Article

A MURINE PLASMACYTOMA MODEL FOR SCREENING ACTIVE DRUGS FOR HUMAN MYELOMAHIRAMATO RN; GHANTA VK; DURANT JR et al.1980; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1980; VOL. 3; NO 4; PP. 395-402; BIBL. 28 REF.Article

PULMONARY TOXICITY ASSOCIATED WITH BISCHLOROETHYLNITROSOUREA (BCN4)DURANT JR; NORGARD MJ; MURAD TM et al.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 90; NO 2; PP. 191-194; BIBL. 13 REF.Article

TUMOR PROLIFERATION AND CHEMOTHERAPY IN IMMUNOSUPPRESSED MICE = PROLIFERATION TUMORALE ET CHIMIOTHERAPIE CHEZ LES SOURIS IMMUNODEPRIMEESGHANTA VK; SHRESTHA K; DURANT JR et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 3; PP. 1097-1100; ABS. ENG; BIBL. 18 REF.; GRAPHArticle

CIS-DICHLORODIAMMINEPLATINUM(II) CHEMOTHERAPY IN EXPERIMENTAL MURINE MYELOMA MOPC 104 E.GHANTA VK; JONES MT; WOODARD DA et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 3; PP. 771-774; BIBL. 10 REF.Article

A RANDOMIZED PROSPECTIVE CLINICAL TRIAL OF ADJUVANT C. PARVUM IMMUNOTHERAPY IN 260 PATIENTS WITH CLINICALLY LOCALIZED MELANOMA (STAGE I): PROGNOSTIC FACTORS ANALYSIS AND PRELIMINARY RESULTS OF IMMUNOTHERAPYBLACH CM; SMALLEY RV; BARTOLUCCI AA et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 6; PP. 1079-1084; BIBL. 24 REF.Article

COMPARISON OF STEROID RECEPTOR LEVELS IN RENAL-CELL CARCINOMA AND AUTOLOGOUS NORMAL KIDNEYHEMSTREET GP III; WITTLIFF JL; SARRIF AM et al.1980; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1980; VOL. 26; NO 6; PP. 769-775; BIBL. 28 REF.Article

THE SUPERIORITY OF COMBINATION CHEMOTHERAPY OVER SINGLE AGENT CHEMOTHERAPY IN SMALL CELL LUNG CARCINOMALOWENBRAUN S; BARTOLUCCI A; SMALLEY RV et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 2; PP. 406-413; BIBL. 29 REF.Article

URINARY HEXOSAMINIDASE IN PATIENTS WITH LUNG CARCINOMABRATTAIN MG; KIMBALL PM; DURANT JR et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 6; PP. 2267-2272; BIBL. 15 REF.Article

BCNU, VELBAN, CYCLOPHOSPHAMIDE, PROCARBAZINE, AND PREDNISONE (BVCPP) IN ADVANCED HODGKIN'S DISEASEDURANT JR; GAMS RA; VELEZ GARCIA E et al.1978; CANCER; USA; DA. 1978; VOL. 42; NO 5; PP. 2101-2110; BIBL. 22 REF.Article

SUBCATEGORIES OF HISTIOCYTIC LYMPHOMA: ASSOCIATIONS WITH SURVIVAL AND REPRODUCIBILITY OF CLASSIFICATION. THE SOUTHEASTERN CANCER STUDY GROUP EXPERIENCEWHITCOMB CC; COUSAR JB; FLINT A et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 11; PP. 2464-2474; BIBL. 20 REF.Article

³¹P NMR SPECTROSCOPY OF IN VIVO TUMORSNG TC; EVANOCHKO WT; HIRAMOTO RN et al.1982; J. MAGN. RESON.; ISSN 0022-2364; USA; DA. 1982; VOL. 49; NO 2; PP. 271-286; BIBL. 35 REF.Article